Stoke Therapeutics Inc buy Credit Suisse Group AG
Start price
08.08.23
/
50%
€4.88
Target price
08.08.24
€21.00
Performance (%)
168.44%
Price
17:31
€13.70
Summary
This prediction is currently active. With a performance of 168.44% the BUY prediction by Credit_Suisse_Group_ is a big success. This prediction currently runs until 08.08.24. The prediction end date can be changed by Credit_Suisse_Group_ at any time. Credit_Suisse_Group_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Stoke Therapeutics Inc | 7.752% | 7.752% |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by Credit_Suisse_Group_ for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "outperform" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $23.00 price target on the stock.
Ratings data for STOK provided by MarketBeat